Continuation versus discontinuation of treatment for severe dementia: randomized, pragmatic, open-label, clinical trial to evaluate the efficacy of continuing drug treatment in patients with severe dementia (STOP-DEM)

Peer Review reports

Original Submission
11 Dec 2018	Submitted	Original manuscript
8 Mar 2019	Author responded	Author comments - Aina Soler Mieras
Resubmission - Version 2
8 Mar 2019	Submitted	Manuscript version 2
22 Mar 2019	Author responded	Author comments - Aina Soler Mieras
Resubmission - Version 3
22 Mar 2019	Submitted	Manuscript version 3
Publishing
27 Mar 2019	Editorially accepted
11 Apr 2019	Article published	10.1186/s12877-019-1122-2

Back to article page